Today

Agents

Chat

Arena

Discover

More

App

Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting - SILO News | Rallies

Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting

SILO•2026-08-19

Asset purchase agreement with Parkview Consulting

Aug. 19 (Reuters) - Silo Pharma Inc. SILO.O:

Silo Pharma entered into an asset purchase agreement with Parkview Consulting on Aug. 18, 2026 - SEC filing
Silo Pharma issued 165,000 shares as consideration for the asset purchase - SEC filing

Related News

Ocean Power Technologies revises FY2026 results after accounting treatment changes, net loss widens to USD 48.9 million

OPTT•2026-08-19

Dianthus Therapeutics director Simon Read disposes of common shares worth $326,148.9

DNTH•2026-08-19

Horizon Kinetics Asset Management relocates to 1270 Avenue of the Americas, New York

RCG•2026-08-19

Mark Zuckerberg encouraged growth over child safety, ex-Meta executive testifies at trial

META•2026-08-19

Upstart CFO Andrea Blankmeyer disposes of 10,175 common shares worth $298,674.14

UPST•2026-08-19